claim
Posted by will
•
April 7, 2026, 4:00 PM
While the urgency to approve new drugs for rare diseases is understandable, we must ensure that these treatments undergo rigorous testing to guarantee their safety and efficacy. Fast-tracking approvals could lead to harmful consequences for patients.
Vote to see results
Responses & Discussion
Log in to add your response to this statement
Log InNo responses yet. Be the first to share your perspective!